| Ytd | -77.20% | |
| 1y | -77.20% |
| Open | 0.25 | Prev Close | 0.25 | Low | 0.24 | High | 0.29 | Mkt Cap | 4.95M |
| Vol | 906.40K | Avg Vol | 881.89K | EPS | -14.32 | P/E | -0.02 | Forward P/E | -0.14 |
| Beta | 0.26 | Short Ratio | 0.13 | Inst. Own | 16.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.59 | 200-d Avg | 7.38 | 1yr Est | 9.60 |
ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasd
ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasd
ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia, and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nas
ADELAIDE, Australia and CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
ADELAIDE, Australia and CAMBRIDGE, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq
ADELAIDE, Australia and CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq
BNC210 demonstrated a statistically significant improvement in post-traumatic stress disorder (PTSD)
ADELAIDE, Australia and CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasda
Small-cap stocks are particularly vulnerable to higher interest rates. So it's not surprising that m
Positive Phase 2b data announced for BNC210 on reduction of total symptom severity and multiple symp
The Company will provide an update on its leading asset BNC210 and their partnership strategy The Co
During Tuesday's session, 275 companies made new 52-week lows.
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durabil
During Tuesday's session, 454 stocks hit new 52-week lows.
During Thursday, 166 stocks hit new 52-week lows.
On Wednesday, 348 companies hit new 52-week lows.
Stocks That Managed to Breach 52-Week Lows Tuesday Morning Before 10 am Tuesday, 44 stocks made new